Internal Medicine Doctors in West Deptford, NJ Accepting Medicare

6 Internal Medicine doctors found. Showing 1 - 6

Brian H. Chernoff, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 935 Kings Hwy Ste 100, West Deptford, NJ 08086 Phone: 856-845-0664    Fax: 856-845-7602

Robert B. Ocasio, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 935 Kings Hwy Ste 100, West Deptford, NJ 08086 Phone: 856-845-0664    Fax: 856-845-7602

Rudolph T Depersia Jr., M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 935 Kings Hwy Ste 100, West Deptford, NJ 08086 Phone: 856-845-0664    Fax: 856-845-7602

Dr. Anjali A Desai, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 196 Grove Ave, Suite C, West Deptford, NJ 08086 Phone: 856-848-7577    Fax: 856-848-6554

Tapati Stalam, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 636 Kings Hwy Ste C, West Deptford, NJ 08096 Phone: 856-845-9666    Fax: 856-845-5666

John C Daly, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 W Red Bank Ave, West Deptford, NJ 08096 Phone: 856-292-8216    Fax: 856-848-3011

News Archive

DNA damage caused by UVA radiation leads to melanoma

A new study by researchers at NYU School of Medicine found that UVA radiation damages the DNA in human melanocyte cells, causing mutations that can lead to melanoma. Melanocytes, which contain a substance called melanin that darkens the skin to protect it from the ultraviolet rays of the sun, are more vulnerable to UVA radiation than normal skin cells because they are unable to repair themselves as efficiently.

Palatin Technologies completes first cohort dosing in bremelanotide trial for sexual dysfunction

Palatin Technologies, Inc. today announced the completion of first cohort dosing in a placebo-controlled, multiple dose study of bremelanotide, its experimental treatment for sexual dysfunction. The primary endpoint in this double-blind safety study is evaluation of blood pressure effects of subcutaneous bremelanotide in men between 45 and 65 years old. The study will also evaluate consistency of plasma exposure of bremelanotide given as repeated subcutaneous injections.

Building a 3D scaffolding to monitor tumor growth in real time and controlled environments

Building three-dimensional scaffolding to guide the growth of tumors in controlled environments, to monitor the evolution of each of their cells in real time and to record the release of tumor metabolites and other indicators of cell activity under different conditions.

New study shows leptin treatment may help reduce type 1 diabetes

Using leptin alone in place of standard insulin therapy shows promise in abating symptoms of type 1 diabetes, UT Southwestern Medical Center researchers report.

Views on Supreme Court case: Both sides stage assault on the Constitution; Obama overreached; Law provides basic needs

As the date of the high court arguments grows nearer, news outlets have a number of editorials and opinions about the health law case.

Read more Medical News

› Verified 2 days ago